Release Date: 04/06/15 17:34 Summary: Ceasing to be a substantial holder from PPT Price Sensitive: No Download Document 103KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%